MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
Background. Monitoring of serum digoxin concentration (SDC) is one of the approaches for controlling the safety of the long-term digoxin treatment, however, the benefits from SDC monitoring in paroxysmal arrhythmias have not been studied.Aim. To evaluate the potential benefits of digoxin laboratory...
Main Authors: | S. F. Zadvorev, A. A. Yakovlev, A. S. Pushkin, S. A. Rukavishnikova, A. E. Filippov, A. G. Obrezan |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2018-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1648 |
Similar Items
-
OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01) -
Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
by: Antonella Colella, et al.
Published: (2022-06-01) -
A Comparison of Verapamil and Digoxin for Heart Rate Control in Atrial Fibrillation
by: Mohammad Afzali Moghadam, et al.
Published: (2012-08-01) -
Digoxin for atrial fibrillation: good, but not too good: a case report
by: Gustavo Luiz Gouvêa de Almeida, et al.
Published: (2022-08-01) -
Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
by: Marcin Wais, et al.
Published: (2024-04-01)